Madison Asset Management’s Novartis NVS Stock Holding History

Madison Asset Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,619	Closed	-$208K	–	354
2025 Q3	$208K	Buy	+1,619	New	+$198K	﹤0.01%	336
2023 Q1	–	Sell	-3,393	Closed	-$308K	–	314
2022 Q4	$308K	Sell	3,393 -359	-10%	-$30.2K	﹤0.01%	300
2022 Q3	$285K	Sell	3,752 -748,018	-100%	-$62M	﹤0.01%	323
2022 Q2	$63.5M	Sell	751,770 -24,882	-3%	-$2.18M	0.99%	30
2022 Q1	$68.2M	Buy	776,652 +3,280	+0.4%	+$284K	0.97%	32
2021 Q4	$67.6M	Sell	773,372 -99,128	-11%	-$8.23M	0.89%	40
2021 Q3	$71.4M	Sell	872,500 -7,525	-0.9%	-$677K	0.98%	31
2021 Q2	$80.3M	Buy	880,025 +122,760	+16%	+$10.9M	1.08%	25
2021 Q1	$64.7M	Sell	757,265 -125,038	-14%	-$11.2M	0.9%	33
2020 Q4	$83.3M	Buy	882,303 +33,915	+4%	+$2.96M	1.22%	21
2020 Q3	$73.8M	Buy	848,388 +57,332	+7%	+$4.97M	1.23%	19
2020 Q2	$69.1M	Sell	791,056 -71,952	-8%	-$6.21M	1.21%	23
2020 Q1	$71.2M	Sell	863,008 -14,643	-2%	-$1.31M	1.46%	13
2019 Q4	$83.1M	Buy	+877,651	New	+$78.8M	1.28%	19

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Madison Asset Management's NVS Position: Q4 2025 in Review

Madison Asset Management sold out of Novartis (NVS) in Q4 2025, closing a stake of 1,619 shares — an estimated $208K sold.

Madison Asset Management first reported a position in NVS in Q4 2019 and held it in 14 quarters. The position peaked at $83.3M in Q4 2020. 1,510 funds tracked by Wall St. Rank hold NVS as of Q4 2025.

Madison Asset Management reported no remaining Novartis position as of Q4 2025 after selling out during the quarter.
Madison Asset Management sold 1,619 Novartis shares in Q4 2025, an estimated $208K.
Madison Asset Management first reported a position in Novartis in Q4 2019 and held it in 14 quarters.
Madison Asset Management's Novartis position peaked at $83.3M in Q4 2020.
1,510 funds tracked by Wall St. Rank held Novartis as of Q4 2025.

Based on Madison Asset Management's 13F filing for Q4 2025, filed 4 Feb 2026.